Tedisamil sesquifumarate

DRUG3 trials

Sponsors

Solvay Pharmaceuticals

Conditions

Atrial FibrillationAtrial Flutter

Phase 3

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects

CompletedNCT00126061

Solvay PharmaceuticalsAtrial Fibrillation, Atrial Flutter

Start: 2004-10-31End: 2006-01-31Updated: 2015-01-16

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

CompletedNCT00126022

Solvay PharmaceuticalsAtrial Fibrillation, Atrial Flutter

Start: 2004-12-31End: 2006-03-31Updated: 2015-01-16

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

CompletedNCT00126074

Solvay PharmaceuticalsAtrial Fibrillation, Atrial Flutter

Start: 2004-10-31End: 2006-03-31Updated: 2015-01-16